AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 277 filers reported holding AVANOS MED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,684,771 | -26.2% | 132,778 | -6.7% | 0.01% | -25.0% |
Q2 2023 | $3,636,685 | -27.1% | 142,336 | -17.2% | 0.01% | -27.3% |
Q1 2023 | $4,987,776 | -2.1% | 171,933 | -8.9% | 0.01% | -8.3% |
Q4 2022 | $5,095,359 | +68.0% | 188,717 | +35.5% | 0.01% | +71.4% |
Q3 2022 | $3,033,000 | +68.0% | 139,269 | +106.9% | 0.01% | +75.0% |
Q2 2022 | $1,805,000 | -3.0% | 67,319 | +21.2% | 0.00% | 0.0% |
Q1 2022 | $1,861,000 | -0.5% | 55,549 | +2.6% | 0.00% | +33.3% |
Q4 2021 | $1,871,000 | -8.8% | 54,151 | -17.7% | 0.00% | -25.0% |
Q3 2021 | $2,052,000 | +50.0% | 65,771 | +74.8% | 0.00% | +100.0% |
Q2 2021 | $1,368,000 | +233.7% | 37,620 | +301.5% | 0.00% | +100.0% |
Q1 2021 | $410,000 | -18.5% | 9,369 | -15.4% | 0.00% | 0.0% |
Q4 2020 | $503,000 | -37.9% | 11,077 | -54.6% | 0.00% | 0.0% |
Q3 2020 | $810,000 | +5.6% | 24,388 | -8.3% | 0.00% | 0.0% |
Q2 2020 | $767,000 | +109.0% | 26,597 | +92.6% | 0.00% | 0.0% |
Q1 2020 | $367,000 | +6.7% | 13,810 | +69.9% | 0.00% | – |
Q1 2019 | $344,000 | -44.6% | 8,126 | -41.4% | 0.00% | -100.0% |
Q4 2018 | $621,000 | -37.0% | 13,864 | -3.6% | 0.00% | 0.0% |
Q3 2018 | $985,000 | – | 14,382 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |